CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.13
-0.09 (-0.98%)
Aug 22, 2025, 4:00 PM - Market closed
CervoMed Market Cap
CervoMed has a market cap or net worth of $84.48 million as of August 22, 2025. Its market cap has decreased by -9.75% in one year.
Market Cap
84.48M
Enterprise Value
50.95M
1-Year Change
-9.75%
Ranking
Category
Stock Price
$9.13
Market Cap Chart
Since June 30, 2008, CervoMed's market cap has increased from $1.50M to $84.48M, an increase of 5,531.82%. That is a compound annual growth rate of 26.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 22, 2025 | 84.50M | 337.82% |
Dec 31, 2024 | 19.30M | -55.43% |
Dec 29, 2023 | 43.30M | 320.39% |
Dec 30, 2022 | 10.30M | -66.88% |
Dec 31, 2021 | 31.10M | -38.90% |
Dec 31, 2020 | 50.90M | 2,213.64% |
Dec 31, 2019 | 2.20M | -67.16% |
Dec 31, 2018 | 6.70M | -60.82% |
Dec 29, 2017 | 17.10M | -26.92% |
Dec 30, 2016 | 23.40M | 25.81% |
Dec 31, 2015 | 18.60M | -69.71% |
Dec 31, 2014 | 61.40M | 361.65% |
Dec 31, 2013 | 13.30M | -22.22% |
Dec 31, 2012 | 17.10M | -60.87% |
Dec 30, 2011 | 43.70M | 54.42% |
Dec 31, 2010 | 28.30M | -75.81% |
Dec 31, 2009 | 117.00M | 39.62% |
Dec 31, 2008 | 83.80M | 5,486.67% |
Jun 30, 2008 | 1.50M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 633.30B |
Johnson & Johnson | 430.71B |
AbbVie | 369.48B |
UnitedHealth Group | 271.56B |
AstraZeneca | 250.11B |
Novartis AG | 246.48B |
Novo Nordisk | 239.90B |
Abbott Laboratories | 230.51B |